curriculum vitae · curriculum vitae . allen m. chen, m.d. department of radiation oncology ....

CURRICULUM VITAE

Allen M. Chen, M.D. Department of Radiation Oncology

University of Kansas School of Medicine 3901 Rainbow Blvd, MS 4033

Kansas City, KS 66160 913-588-3612 (office); 408-761-3874 (cell)

[email protected] CURRENT APPOINTMENT Professor and Chair, University of Kansas School of Medicine Associate Director, University of Kansas, NCI-designated Cancer Center Residency Training Program Director, University of Kansas School of Medicine PREVIOUS EXPERIENCE 7/2015-10/2016 Professor and Vice-Chair, UCLA School of Medicine 7/2013-6/2015 Associate Professor and Vice-Chair, UCLA School of Medicine 7/2012-6/2013 Associate Professor, University of California, Davis, School of Medicine 10/2008-6/2012 Assistant Professor-in-Residence, University of California, Davis 7/2007-9/2008 Clinical Assistant Professor, University of California, Davis 8/2006-6/2007 Staff Physician, Coastal Radiation Oncology, San Luis Obispo, CA EDUCATION 2001 M.D., Yale University School of Medicine, New Haven, CT 1996 B.A., Biochemistry and History (double major), Cornell University, Ithaca, NY POST-GRADUATE 2003-06 Residency, Radiation Oncology, University of California, San Francisco, CA 2004-05 Chief Residency, Radiation Oncology, University of California, San Francisco, CA 2002-03 Residency, Radiation Oncology, M.D. Anderson Cancer Center, Houston, TX 2001-02 Internship, Internal Medicine, Kaiser Permanente Medical Center, Santa Clara, CA CERTIFICATIONS American Board of Radiology #53354; CA License #A84562; KS License #0439509 DEA #BC9043744; UPIN #I55424; NPI #1518992981

A.Chen, of 37

PROFESSIONAL MEMBERSHIPS 2011-present Southwestern Oncology Group (SWOG) 2008-present Association for Directors of Radiation Oncology Programs 2008-present American College of Radiology (ACR) 2007-present Radiation Therapy Oncology Group (RTOG)/NRG Oncology 2007-present American Academy of Otolaryngology- Head and Neck Surgery 2002-present American Society for Radiation Oncology (ASTRO) 2002-present American Society of Clinical Oncology (ASCO) 2002-present Radiological Society of North America (RSNA) 2000-present American Radium Society 1997-present American Medical Association HONORS AND AWARDS 2016-17 Association of Residents in Radiation Oncology (ARRO), Appointed Advisor 2015-17 President (2 yr term), Association for Directors of Radiation Oncology Programs 2015 UCLA-David Geffen School of Medicine, Faculty Executive Council (Elected) 2014 UCLA Faculty Leadership Development Program (Annual Course, 2 hrs/wk) 2013 ASTRO Cancer Imaging and Radiation Symposium, Travel Grant Winner 2013 RTOG Study Chair Workshop 2012 Most downloaded article, Int J Radiat Oncol Biol Phys 2009-13 University of California, Davis, School of Medicine, Mentoring Award 2009-16 Best Doctors in America 2010-2012 ASTRO/ARRO, Educator of the Year 2009 RTOG/Simon Kramer Young Investigator Award 2007 American Society for the Prevention of Cruelty to Animals, Volunteer Award 2005 NCI/ASTRO- Young Investigator Workshop, Travel Grant Winner 2003 American Radium Society, Young Oncologist Essay Award 2003 San Antonio Breast Cancer Symposium, Astra-Zeneca Scholarship (best abstract) 2001 Indian Health Service/ Public Health Commendation for Service 2001 Gold Foundation Essay Contest- “Humanism in Medicine,” Recognition 2001 Yale School of Medicine Doctorate Thesis, “Current Status of Breast Conservation” FOREIGN LANGUAGES Mandarin Chinese (fluent); Spanish (conversational) CLINICAL INTERESTS Head and neck cancer, Lung cancer, Stereotactic body radiotherapy (SBRT), Re-irradiation, Breast cancer, Sarcoma, Accelerated partial breast irradiation, Image-guided radiotherapy (IGRT), Clinical trials, Health disparities, Survivorship, Quality assurance, Radiation physics, Community outreach

A.Chen, of 37

PROFESSSIONAL SERVICE 2017-present ACR, Appropriateness Criteria Steering Committee 2016-present RSNA, Refresher Course Steering Committee 2016-present ASTRO, CME Journal Review, Task Force 2016-present ASTRO, Webinar Task Force 2015-present Association for Directors of Radiation Oncology Programs, Executive Committee 2015-present National Cancer Institute, Head and Neck Recurrent/Metastatic Task Force 2015-present National Cancer Institute, Rare Tumors Task Force 2015-present UCLA-David Geffen School of Medicine, Faculty Executive Council 2013-present ASTRO, Education Committee 2014-present ASTRO State-of-the-Art Meeting, Organizing Committee 2014-present UCLA Radiation Oncology, Committee on Clinical Trials 2014-present UCLA Radiation Oncology, Committee on Academic Affairs 2014-present ACRO/UCLA Radiation Oncology Education Symposium, Organizer 2014-present Consultant, Barretos Cancer Hospital, Brazil 2014-present Consultant, Aga Khan Hospital, Pakistan 2013-present Editorial Board, Head Neck 2013-present Advisory Board, Support for People with Oral Head and Neck Cancer (SPOHNC) 2013-present UCLA Radiation Oncology Residency and Fellowship Training Program Director 2013-present UCLA Medical Student Clerkship Director 2013-present UCLA Graduate Medical Education Committee, Member 2013-present UCLA Head and Neck Cancer Integrated Practice Unit, Pilot Group 2013-present UCLA Radiation Oncology Student Interest Group, Faculty Advisor 2013-present Grant reviewer (ad hoc), National Cancer Institute, Belgium 2013-present Grant reviewer (ad hoc), National Cancer Institute, Italy 2012-present Grant reviewer (ad hoc), National Cancer Institute, Canada 2010-2013 ASTRO, Scientific Committee 2010-present ASTRO, Abstract Reviewer for Annual Meeting 2010-present American Board of Radiology, Exam Question Writer 2010-present ACR Exam Question Writer 2012-present SWOG, Thoracic Committee 2010-present RTOG/NRG, Head and Neck Steering Committee 2009-11 RTOG, Advanced Technologies Committee 2011-13 UC Davis School of Medicine, Admissions Committee, Member 2011-13 UC Davis Cancer Center, Protocol Accrual and Monitoring Committee, Chair 2009-13 UC Davis Cancer Center, Failure Mode and Effects Analysis (FMEA) Committee 2008-13 UC Davis Radiation Oncology, Research Strategy Co-Chair 2008-13 UC Davis Radiation Use and Safety Committee, Member 2008-13 UC Davis Radiation Oncology, Residency Training and Fellowship Director 2008-13 UC Davis Graduate Medical Education Committee, Member 2008-10 UC Davis Radiation Oncology, RTOG Principal Investigator 2007-13 UC Davis Cancer Center, Scientific Review Committee, Voting member 2007-13 UC Davis Radiation Oncology, Medical Student Clerkship, Director 2003-11 Cornell University, California Alumni Admissions Committee, Interviewer 2007-08 UC Davis Radiation Oncology, Search Committee, Department Chair

A.Chen, of 37

SERVICE TO PROFESSIONAL PUBLICATIONS 2016-present Editorial board, Frontiers in Oncology 2013-present Editorial board, Head Neck 2013-present Editorial board, Support for people with oral head neck cancer 2015-present Reviewer, JAMA- Oncology 2013-present Reviewer, Lancet Oncology 2013-present Reviewer, Cancer Medicine 2013-present Reviewer, BMC Cancer 2013-present Reviewer, Journal of Neurooncology 2012-present Reviewer, World Journal of Otorhinolaryngology 2012-present Reviewer, Cancer Imaging 2012-present Reviewer, Expert Review Anticancer Therapy 2010-present Reviewer, Practical Radiation Oncology 2010-present Reviewer, Technology in Cancer Research and Treatment 2010-present Reviewer, Clinical Otolaryngology 2010-present Reviewer, Oral Oncology 2010-present Reviewer, Clinical Cancer Research 2010-present Reviewer, Cancer Sciences and Therapy 2009-present Reviewer, Journal of Clinical Oncology 2009-present Reviewer, Cancer Journal 2009-present Reviewer, Radiation Oncology 2009-present Reviewer, Clinical Lung Cancer 2009-present Reviewer, British Journal of Radiology 2009-present Reviewer, Radiographics 2009-present Reviewer, Radiology 2008-present Reviewer, Medical Physics 2008-present Reviewer, Journal of Clinical Research and Therapeutics 2008-present Reviewer, Laryngoscope 2007-present Reviewer, Head and Neck 2007-present Reviewer, World Journal of Otorhinolaryngology 2007-present Reviewer, Journal of Experimental Therapeutics and Oncology 2007-present Reviewer, American Journal of Clinical Oncology and Oncology 2005-present Reviewer, Archives of Otolaryngology- Head and Neck Surgery 2004-present Reviewer, Cancer 2003-present Reviewer, Radiotherapy and Oncology 2003-present Reviewer, International Journal of Radiation Oncology, Biology, Physics PUBLIC SERVICE 2013-15 Los Angeles Kitchen- Volunteer for homeless clinic 2008-13 UC Davis Volunteer Preceptor, Student-Run Clinics for Underserved 2009-12 Sacramento Bark in the Park 5K Race, Event Volunteer 2009-11 Sacramento High School, Volunteer Mentor for At-Risk Youth 2009-11 Sacramento Society for Prevention of Cruelty to Animals, Volunteer

A.Chen, of 37

RESEARCH INTERESTS Clinical trials; Translational research; Technology and innovation; Quality of life; Radiation response; Medical education; Health disparities; Bioinformatics HOBBIES Tennis, Volleyball, Classical piano, Jazz saxophone, Cooking, World history and travel, English literature, Gardening, Movies, Home repairs, Leisure reading, Animal rescue and adoption PROTOCOLS/GRANTS UCDCC# 168, Principle investigator: “Oral mucosal cell sampling in head and neck radiotherapy for molecular analysis and prognostic utility: A pilot feasibility study” ($10,000 funded through University of California Seed Grant, completed 2009) UCDCC#200614108, Principle investigator: “Molecular phenotypes of head and neck cancer underlying tumor remodeling as assessed by serial HPV measurements in serum and mucosa” ($10,000 funded through University of California Seed Grant, completed 2013) UCDCC#195, Principle investigator: “Comparison of daily versus less-than-daily image-guidance protocols for head and neck cancer,” ($5,000 funded through Radiological Society of North America, completed 2010) BARDA#20133, Co-Principle investigator: Biomedical Advanced Research and Development Authority, Collaborator: “Point of care or high-throughput biological assays (biodosimetry) for determining absorbed ionizing radiation dose after radiologic and nuclear events” (Funded 2.5 million dollars, 2 years, 5% effort, 2009-2011, completed) California Cancer Consortium (CCC) program (N01 institutional grant), Co-Principle investigator: “Developing infrastructure for phase I/II trials for solid tumors” (Funded 2 million dollars, 1% effort, 2009-2013, completed) UCDCC#105, Co-Principle investigator, “Establishment of an image-guided radiotherapy (IGRT) archive for research” ($10,000, University of California Seed Grant, completed 2008) SWOG#1206, Principle investigator (national): Southwestern Oncology Group, S1206 “A phase I/II study of ABT-888 added to chemoradiotherapy with carboplatin and paclitaxel for unresectable stage III non-small cell lung cancer” (Funding through SWOG) NRG#1438, Co-Principle investigator (national): “A randomized phase II study of SBRT plus anti-PD-1 antibody versus anti-PD-1 antibody alone for oligo-metastatic head and neck carcinoma” (Funding through RTOG/NRG- Astra-Zeneca)

A.Chen, of 37

PUBLICATIONS

1. Chen AM, Felix C, Wang PC, Hsu S, Basehart V, Garst J, Beron P, Wong D, Rosove MH,

Rao S, Melanson H, Kim E, Palmer D, Qi L, Kelly K, Steinberg MS, Kupelian PA, Daly ME. Reduced-dose radiotherapy for human papillomavirus-associated squamous cell carcinoma of the oropharynx. Lancet Oncol 2017; 18: 803-811.

2. Chen AM, Cao M, Hsu S, Lamb J, Mikaelian A, Yang Y, Agazaryan N, Low DA, Steinberg ML. Magnetic resonance-imaging guided radiotherapy for head and neck cancer: initial clinical experience. Clin Trans Oncol 2017; 21: 167-175.

3. Chen AM, Hsu S, Felix C, Garst J, Yoshizaki T. Effect of psychosocial distress on outcomes of patients treated by radiation therapy for head and neck cancer. Laryngoscope 2017; July 17 [e-pub ahead of print].

4. Chen AM, Yoshizaki T, Velez MA, Mikaeilian A, Hsu S, Cao M. Tolerance of the brachial plexus to high-dose re-irradiation. Int J Radiat Oncol Biol Phys 2017; 98: 83-90.

5. Chen AM, Cao M, Hsu S, Lamb J, Mikaeilian A, Yang Y, Agazaryan N, Low DA, Steinberg

ML. Magnetic resonance imaging-guided re-irradiation for recurrent head and neck cancer. Advances Radiat Oncol 2017; 2: 45-51.

6. Chen AM, Chin R, Beron P, Yoshizaki T, Cao M. Inadequate target delineation and local-regional recurrence in the setting of radiation therapy for human papillomavirus-positive oropharyngeal cancer. Radiother Oncol 2017; 123: 412-418.

7. Rwigema JC, Choi J, Lee NY, Heron D, Chen AM. Re-irradiation therapy for locally recurrent head and neck cancer: A national survey of practice patterns. Cancer Invest 2017; 24: 1-10.

8. Juarez JE, Choi J, St John M, Abemayor E, TenNapel M, Chen AM. Patterns of care for elderly patients with locally advanced head and neck cancer. Int J Radiat Oncol Biol Phys 2017; 15: 767-774.

9. Hegde J, Shaverdian N, Daly ME, Felix C, Wong D, Rosove MH, Garst J, Wang PC, Veruttipong D, Rao S, Fragoso RC, Riess J, Steinberg ML, Chen AM. Patient-reported quality of life outcomes after de-escalated chemoradiation for human papillomavirus-positive oropharyngeal carcinoma: Findings from a phase II trial. Cancer 2017; July 20 [e-pub ahead of print].

10. Hegde J, Chen AM, Chin R. Advances in radiation oncology: What to consider. Otolaryngol Clinic North America 2017; May 17 [e-pub ahead of print].

A.Chen, of 37

11. Chen AM, Hsu S, Meshman J, Chin R, Beron P, Abemayor E, St. John M. Effect of daily fraction size on laryngo-esophageal dysfunction after chemoradiation for squamous cell carcinomas of the larynx and hypopharynx. Head Neck 2017; Mar 16 [e-pub ahead of print].

12. Chen AM, Meshman J, Hsu S, Yoshizaki T, Abeymayor E, St. John M. Oropharynx-directed ipsilateral irradiation for 16-positive squamous cell carcinoma involving the cervical lymph nodes of unknown primary origin. Head Neck; July 21 [e-pub ahead of print].

13. Velez MA, Veruttipong D, Wang PC, Chin R, Beron P, Abemayor E, St John M, Chen AM.

Re-irradiation for recurrent and second primary cancers of the head and neck. Oral Oncology 2017; 67: 46-51.

14. Weidhaas JB, Harris J, Schaue D, Chen AM, Chin R, Axelrod R, El-Naggar AK, Singh AK, Galloway TJ, Raben D, Wang D, Matthiesen C, Avizonis VN, Manon RR, Yumen O, Nguyen-Tan PF, Trotti A, Skinner H, Zhang Q, Ferris RL, Sidransky D, Chung CH. The KRAS-variant and cetuximab response in head and neck squamous cell carcinoma: secondary analysis of a randomized clinical trial. JAMA Oncology 2017; 3: 483-491.

15. Wang C, King CR, Kamrava M, Iwamoto KS, Chen AM, Low D, Kupelian PA, Steinberg ML. Patterns of solid and hematopoietic second malignancy after local therapy for prostate cancer. Radiother Oncol 2017; 123: 133-138.

16. Meshman J, Wang PC, Chin R, John MS, Abemayor E, Bhuta S, Chen AM. Prognostic significance of p16 in squamous cell carcinoma of the larynx and hypopoharynx. Am J Otolaryngol 2017; 38: 31-37.

17. Raghavan G, Kishan AU, Cao M, Chen AM. Anatomic and dosimetric changes in patients with head and neck cancer treated with an integrated MRI tri-cobalt therapy device. Br J Radiol 2016; 89: 20160624.

18. Hess CB, Thompson H, Benedict SH, Seibert JA, Wong K, Vaughan AT, Chen AM. Exposure risks among children undergoing radiation therapy: Considerations in the era of image-guided radiotherapy. Int J Radiat Oncol Biol Phys 2016; 94: 978-92.

19. Vlashi E, Chen AM, Boyrie S, Yu G, Frohnen P, Brower PA, Pajonk F. Radiation-induced dedifferentiation of head and neck cancer cells into cancer stem cells depends on HPV status. Int J Radiat Oncol Biol Phys 2016; 94: 1198-206.

20. Li Y, Chen AM, Hu P, Cao M, Sheng K, Lee P, Low D. Longitudinal diffusion MRI for

treatment response assessment: preliminary experience using an MRI-guided tri-cobalt 60 radiotherapy system. Med Phys 2016; 43: 1369-1373.

21. Grossi Marconi D, da Costa Resende B, Rauber E, de Cassia Soares P, Fernandes JM Junior, Mehta N, Lopes Carvalho A, Kupelian PA, Chen AM. PLoS One 2016; 11: e0156544.

A.Chen, of 37

22. Shenoy D, Packianathan S, Chen AM, Vijayakumar S. Do African-American men need separate prostate cancer screening guidelines? BMC Urol 2016; 9: 604-609.

23. Ling DC, Hess CB, Chen AM, Daly ME. Comparison of toxicity between intensity-modulated radiotherapy and 3-dimensional conformal radiotherapy for locally advanced non-small cell lung cancer. Clin Lung Cancer 2016; 17: 18-23.

24. Chen AM, Wong D, St. John M. Evolving treatment paradigms for HPV-related oropharynx cancer. Current Cancer Therapy Rev 2015; 10: 353-359.

25. Chen AM, Daly ME, Luu Q, Donald PJ, Farwell DG. Comparison of functional outcomes and quality of life between transoral surgery and definitive chemoradiotherapy for oropharyngeal cancer. Head Neck 2015; 37: 381-385.

26. Yu Y, Daly ME, Farwell DG, Luu Q, Gandour-Edwards R, Donald PJ, Chen AM. Level IB nodal involvement in oropharyngeal carcinoma: implications for submandibular gland-sparing intensity-modulated radiotherapy. Laryngoscope 2015; 125: 608-614.

27. Rwigema JC, Nguyen D, Heron DE, Chen AM, Lee P, Wang PC, Vargo JA, Low DA,Huq MS, Tenn S, Steinberg ML, Kupelian P, Sheng K. 4pi noncoplanar stereotactic body radiotherapy for head and neck cancer: potential to improve local control and late toxicity. Int J Radiat Oncol Biol Phys 2015; 91: 401-409.

28. Harris BN, Biron VL, Donald P, Farwell DG, Luu QC, Bewley AF, Chen AM, Daly ME. Primary surgery versus chemoradiation treatment of advanced hypopharygneal squamous cell carcinoma. JAMA Otolaryngol Head Neck Surg 2015; 141: 636-640.

29. Hayes JT, David EA, Qi L, Chen AM, Daly ME. Risk of pneumonitis after stereotactic body radiation therapy in patients with previous anatomic lung resection. Clin Lung Cancer 2015; 16: 379-384.

30. Qi XS, Santhanam A, Neylon J, Min Y, Armstrong T, Sheng K, Staton RJ, Pukala J, Pham A,

Low DA, Lee SP, Steinberg M, Manon R, Chen AM, Kupelian P. Near real-time assessment of anatomic and dosimetric variations for head-and-neck radiation therapy via graphics processing unit-based dose deformation framework. Int J Radiat Oncol Biol Phys 2015; 92: 415-422.

31. Daly ME, Chen AM, Mayadev J, Stern RS. Enhanced surface dose via fine brass mesh for a complex skin cancer of the head and neck: Report of a technique. Pract Radiat Oncol 2015; 5: 16-20.

32. Gomez CL, Chen AM. Locoregional control after neoadjuvant chemotherapy and

conservative treatment for locally advanced breast cancer. Breast diseases 2015; 26: 65-67.

A.Chen, of 37

33. Chen AM, Wang PC, Daly ME, Cui J, Hall WH, Vijayakumar S, Phillips TL, Farwell DG, Purdy JA. Dose-volume modeling of brachial plexus-associated neuropathy after radiation therapy for head-and-neck cancer: Findings from a prospective screening protocol. Int J Radiat Oncol Biol Phys 2014; 88: 771-777.

34. Chen AM, Daly ME, Cui J, et al. Long-term clinical experience with helical tomotherapy for

head and neck cancer. J Radiat Oncol 2014; 3: 355-361.

35. Chen AM, Daly ME, Cui J, Wooten OH, Farwell DG, Purdy JA. Helical tomotherapy with simultaneous-integrated boost dose painting for the treatment of synchronous primary cancers involving the head and neck. Br J Radiol 2014; 87(1040): 20130697.

36. Hess CB, Chen AM. Measuring psychosocial functioning in the radiation oncology clinic: a systematic review. Psychooncology 2014; 23: 841-854.

37. Khodayari B, Michaud AL, Stanic S, Wooten OH, Dublin A, Purdy JA, Chen AM. Evaluation

of hippocampus dose for patients undergoing intensity-modulated radiotherapy for nasopharyngeal carcinoma. Br J Radiol 2014; 87:20130474.

38. Kishan AU, Cui J, Wang PC, Daly ME, Purdy JA, Chen AM. Quantification of gross tumor volume changes between simulation and first day of radiation therapy for patients with locally advanced malignancies of the lung and head/neck. J Med Imaging Rad Onc 2014; 58: 618-624.

39. Daly ME, Beckett LA, Chen AM. Does early posttreatment surveillance imaging affect

subsequent management following stereotactic body radiation therapy for early-stage non-small cell lung cancer? Pract Radiat Oncol 2014; 4: 240-246.

40. Rwigema JC, Chen AM, Wang PC, Lee JM, Garon E, Lee P. Incidental mediastinal dose does

not explain low mediastinal node recurrence rates in patients with early-stage NSCLC treated with stereotactic body radiotherapy. Clin Lung Cancer 2014; 15: 287-293.

41. Mayadev J, Daly M, Chen AM, Bold R, Chew H. The potential role of radiation therapy to the

primary site of disease in stage IV breast cancer presenting with synchronous metastasis. Clin Breast Cancer 2014; 14: 10-12.

42. Mayadev J, Fish K, West DW, Chen A, Martinez SR, Valicenti R, Phillips T. The utilization

and impact of a post mastectomy radiation boost for invasive breast cancer. Pract Radiat Oncol 2014; 4: e269-278.

43. Hess CB, Rash DL, Daly ME, Farwell DG, Bishop J, Vaughan AT, Wilson MD, Chen AM.

Competing causes of death and medical comorbidities among patients with human papillomavirus-positive versus human papillomavirus-negative oropharyngeal carcinoma and impact on adherence to radiotherapy. JAMA Otolaryngol Head Neck Surg 2014; 140: 312-316.

A.Chen, of 37

44. Chen AM, Vazquez E, Michaud AL, Farwell DG, Purdy JA. Functional and quality-of-life outcomes after reirradiation for head and neck cancer. Laryngoscope 2014; 124: 807-812.

45. Chen AM, Daly ME, Farwell DG, Vazquez E, Courquin J, Lau DH, Purdy JA. Quality of life among long-term survivors of head and neck cancer treated by intensity-modulated radiotherapy. JAMA Otolaryngol Head Neck Surg 2014; 140: 129-133.

46. Yoshida EJ, Garcia J, Eisele DW, Chen AM. Salivary gland malignancies in children. Int J Pediatr Otorhinolaryngol 2014; 78: 174-178.

47. Chen AM, Yu Y, Daly ME, Farwell DG, H Benedict S, Purdy JA. Long-term experience with reduced planning target volume margins and intensity-modulated radiotherapy with daily image-guidance for head and neck cancer. Head Neck 2014; 36: 1766-1772.

48. Chen AM, Vazquez E, Courquin J, Donald PJ, Farwell DG. Tobacco use among long-term

survivors of head and neck cancer treated with radiation therapy. Psychooncology 2014; 23: 190-194.

49. Batth S, Caudell JJ, Chen AM. Practical considerations in reducing swallowing dysfunction

following concurrent chemoradiotherapy using intensity-modulated radiotherapy for head and neck cancer. Head Neck 2014; 36: 291-298.

50. Lau VH, Aouad R, Farwell DG, Donald PJ, Chen AM. Patterns of nodal involvement for

clinically N0 salivary gland carcinoma: Refining the role of elective neck irradiation. Head Neck 2014; 26: 1435-1439.

51. Khodayari B, Daly ME, Bobinski M, Farwell DG, Shelton DK, Chen AM. Observation versus

neck dissection for positron-emission tomography-negative lymphadenopathy after chemoradiotherapy. Laryngoscope 2014; 124: 902-906.

52. Yu Y, Michaud AL, Sreeraman R, Liu T, Purdy JA, Chen AM. Comparison of daily versus

non-daily image-guided radiotherapy protocols for patients treated by intensity-modulated radiotherapy for head and neck cancer. Head Neck 2014; 36: 992-997.

53. Batth SS, Sreeraman R, Dienes E, Beckett LA, Daly ME, Cui J, Mathai M, Purdy JA, Chen

AM. Clinical-dosimetric relationship between lacrimal gland dose and ocular toxicity after intensity-modulated radiotherapy for sinonasal tumors. Br J Radiol 2013; 86: 20130459.

54. Chen AM, Zhara T, Daly ME, Farwell DG, Luu Q, Gandour-Edwards R, Coleman M, Vaughan AT. Definitive radiation therapy alone for human papillomavirus-related head and neck cancer. Head Neck 2013; 35: 1652-1656.

55. Healy E, Anderson S, Cui J, Beckett L, Chen AM, Perks J, Stern R, Mayadev J. Skin dose effects of postmastectomy chest wall radiation therapy using brass mesh as an alternative to tissue equivalent bolus. Pract Radiat Oncol 2013; 3: e45-53.

A.Chen, of 37

56. Chen AM, Daly ME, Cui J, Mathai M, Benedict S, Purdy JA. Clinical outcomes among head and neck cancer patients treated with intensity-modulated radiotherapy with and without adaptive re-planning. Head Neck 2013; 36: 1541-1546.

57. Daly ME, Lau DH, Farwell DH, Luu Q, Donald PJ, Chen AM. Feasibility and toxicity of

concurrent chemoradiation for elderly patients with head and neck cancer. Am J Otolaryngol 2013; 34: 631-635.

58. Yoshida E, Aouad R, Fragoso R, Farwell DG, Gandour-Edwards R, Donald PJ, Chen AM. Improved clinical outcomes with multi-modality therapy for sinonasal undifferentiated carcinoma of the head and neck. Am J Otolaryngol 2013; 34: 658-663.

59. Chen AM, Daly ME, Vazquez E, Courquin J, Luu Q, Donald PJ, Farwell DG. Depression among long-term survivors of head and neck cancer treated with radiation therapy. JAMA Otolaryngol Head Neck Surg 2013; 139: 885-889.

60. Sreeraman R, Vijayakumar S, Chen AM. Correlation of radiation treatment interruptions with psychiatric disease and performance status in head and neck cancer patients. Support Care Cancer 2013 Dec 21: 3301-3306.

61. Chen AM, Lau VH, Farwell DG, Luu Q, Donald PJ. Mucoepidermoid carcinoma of the

parotid gland treated by surgery and postoperative radiation therapy: Clinicopathologic correlates of outcome. Laryngoscope 2013; 123: 3049-3055.

62. Daly ME, Perks J, Chen AM. Patterns-of-care for thoracic stereotactic body radiotherapy

(SBRT) among practicing radiation oncologists in the United States. J Thoracic Oncol 2013; 8: 202-207.

63. Chen AM, Li J, Beckett L, Zhara T, Michaud AL, Farwell DG, Luu Q, Purdy JA, Vaughan

AT. Differential response rates in vivo to irradiation among patients with human papillomavirus (HPV) positive and negative oropharyngeal cancer. Laryngoscope 2013; 123: 152-157.

64. Healy E, Anderson S, Cui J, Beckett L, Chen AM, Perks J, Stern R, Mayadev J. Skin dose

effects of postmastectomy chest wall radiation therapy using brass mesh as an alternative to tissue equivalent bolus. Practical Rad Onc 2013; 3: 45-50.

65. Chen AM, Hall WH, Li J, Beckett LA, Farwell DG, Lau DH, Purdy JA. Brachial plexus-

associated neuropathy after high-dose radiation therapy for head and neck cancer. Int J Radiat Oncol Biol Phys 2012; 84: 165-169.

66. Chen AM, Farwell DG, Luu Q, Vazquez EG, Lau DH, Purdy JA. Intensity-modulated radiotherapy is associated with improved global quality of life among long-term survivors of head and neck cancer. Int J Radiat Oncol Biol Phys 2012; 84: 170-175.

http://www.ncbi.nlm.nih.gov/pubmed/23754320



A.Chen, of 37

67. Chen AM, Yang CC, Marsano J, Liu T, Purdy JA. Intensity-modulated radiotherapy for nasopharyngeal carcinoma: improvement of the therapeutic ratio with helical tomotherapy versus segmental multileaf collimator-based techniques. Br J Radiol 2012; 85: 537-543.

68. Chen AM, Cheng S, Farwell DG, Luu Q, Donald P, Boggan J, Franklin S, Purdy JA. Utility

of daily image guidance with intensity-modulated radiotherapy for tumors of the base of skull. Head Neck 2012; 34: 763-770.

69. Chen AM, Purdy JA. In response to Yazici (letter). Int J Radiat Oncol Biol 2012; 84: 1.

70. Yi SK, Hall WH, Mathai M, Dublin AB, Gupta V, Purdy JA, Chen AM. Validating the

RTOG-endorsed brachial plexus contouring atlas: An evaluation of reproducibility among patients treated by IMRT for head and neck cancer. Int J Radiat Oncol Biol Phys 2012; 82: 1060-1064.

71. Perks J, Stanic S, Mathai M, Harse R, Siefkin A, Valicenti R, Purdy JA, Chen AM. Failure

mode and effects analysis for delivery of lung stereotactic body radiotherapy. Int J Radiat Oncol Biol Phys 2012; 83: 1324-1329.

72. Hou WH, Daly ME, Lee NY, Farwell DG, Luu Q, Chen AM. Racial disparities in the use of

voice-preservation for locally advanced laryngeal cancer. Arch Otolaryngology- Head Neck Surg 2012; 138: 648-699.

73. Lau VH, Goodrich S, Farwell DG, Luu Q, Stuart K, Courquin J, Chen AM. Voice quality after

definitive radiation therapy for early-stage and locally-advanced laryngeal cancer. Head Neck 2012; 34: 943-948.

74. Stanic S, Mathai M, Mayadev J, Do LV, Purdy JA, Chen AM. Addition of a third field

significantly increases dose to the brachial plexus for patients undergoing tangential whole-breast radiotherapy after lumpectomy. Med Dosim 2012; 37: 127-130.

75. Hess CB, Chen AM. Global and health-related quality of life after radiation therapy for head

and neck cancer. Expert Rev Anticancer Ther 2012; 12: 1469-1477.

76. Martinez S, Tseng WH, Canter RJ, Chen SL, Chen AM, Bold RJ. Do radiation use disparities influence survival in breast cancer? Cancer 2012; 118: 196-204.

77. Li BQ, Chen M, Nori D, Chao KS, Chen AM, Chen SL. Adjuvant radiation therapy and

survival for pure tubular breast carcinoma- Experience from the SEER database. Int J Radiat Oncol Biol Phys 2012; 84: 23-29.

78. Yi SK, Mak W, Yang CC, Cui J, Purdy JA, Chen AM, Monjazeb AM, Do L. Development of a standardized method for contouring the lumbosacral plexus: A preliminary dosimetric analysis of this organ at risk among 15 patients treated with IMRT for lower gastrointestinal cancers and the incidence of radiation induced lumbosacral plexopathy. Int J Radiat Oncol Biol Phys 2012; 84: 376-382.

A.Chen, of 37

79. Chen AM, Farwell DG, Luu Q, Cheng S, Donald PJ, Purdy JA. Prospective trial of high-dose re-irradiation using daily image-guidance with intensity-modulated radiotherapy for recurrent and second primary head and neck cancer. Int J Radiat Oncol Biol Phys 2011; 80: 669-76.

80. Chen AM, Phillips TL, Lee NY. Practical considerations in the re-irradiation of recurrent and second primary head and neck cancers: Who, why, how, and how much? Int J Radiat Oncol Biol Phys 2011; 81: 1211-1219.

81. Chen AM, Farwell DG, Lau DH, Li BQ, Luu Q, Donald PJ. Radiation therapy in the

management of head and neck cancer of unknown primary origin: How does the addition of concurrent chemotherapy affect the therapeutic ratio? Int J Radiat Oncol Biol Phys 2011; 81: 346-352.

82. Chen AM, Li BQ, Farwell DG, Marsano J, Vijayakumar S, Purdy JA. Improved dosimetric

and clinical outcomes with intensity-modulated radiotherapy for head and neck cancer of unknown primary origin. Int J Radiat Oncol Biol Phys 2011; 79: 756-762.

83. Chen AM, Chen LM, Vaughan A, Sreeraman R, Farwell DG, Luu Q, Lau DH, Stuart K, Purdy

JA, Vijayakumar S. Tobacco smoking during radiation therapy for head and neck cancer is associated with unfavorable outcome. Int J Radiat Oncol Biol Phys 2011; 79: 414-419.

84. Chen AM, Farwell DG, Luu Q, Chen LM, Vijayakumar S, Purdy JA. Marginal misses after

postoperative intensity-modulated radiotherapy for head and neck cancer. Int J Radiat Oncol Biol Phys 2011; 80: 1423-1429.

85. Chen AM, Lara PN, Jr. Chemoradiotherapy for non-small cell lung cancer- does a “standard”

exist? Nat Rev Clin Oncol 2011; 8: 5-6. 86. Chen AM, Farwell DG, Luu Q, Donald PJ, Perks J, Purdy JA. Evaluation of the planning

target volume in the treatment of head and neck cancer with intensity-modulated radiotherapy: What is the appropriate expansion margin in the setting of daily image guidance? Int J Radiat Oncol Biol Phys 2011; 81: 943-949.

87. Chen AM, Hall WH, Li BQ, Guiou M, Wright C, Mathai M, Dublin A, Purdy JA. Intensity-

modulated radiotherapy increases dose to the brachial plexus compared to conventional radiotherapy for head and neck cancer. Br J Radiol 2011; 84: 58-63.

88. Chen AM, Marsano J, Farwell DG, Mathai M, Purdy JA. Comparison of IMRT techniques in

the radiotherapeutic management of head and neck cancer: Is tomotherapy “better” than step-and-shoot IMRT? Technol Cancer Res Treat 2011; 10: 171-177.

89. Chen AM, Chen LM, Vaughan A, Farwell DG, Luu Q, Purdy JA, Vijayakumar S. Head and neck cancer among lifelong never-smokers and ever-smokers: Matched-paired analysis of outcomes after radiation therapy. Am J Clin Oncol 2011; 34: 270-275.

A.Chen, of 37

90. Chen AM, Purdy JA. In response to Salem et al (letter). Int J Radiat Oncol Biol 2011; 80: 5; 1599-1560.

91. Klein EA, Guiou M, Farwell DG, Luu Q, Lau DH, Vaughan A, Vijayakumar S, Chen AM.

Primary radiation therapy for head and neck cancer in the setting of human immunodeficiency virus. Int J Radiat Oncol Biol Phys 2011; 79: 60-64.

92. Li BQ, Gandour-Edwards R, Bobinski M, Farwell DG, Chen AM. Over-staging of cartilage

invasion by multidetector CT scan for locally advanced laryngeal cancer and its potential effect on the use of organ preservation with chemoradiation. Br J Radiol 2011; 84: 64-69.

93. Yi S, Calhoun R, Mathai M, Purdy JA, Chen AM. Changes in position and volume of lung

cancer target volumes during stereotactic body radiotherapy (SBRT): Is image guidance necessary? Technol Cancer Res Treat 2011; 10: 495-504.

94. Lau VH, Chen LM, Farwell DG, Luu Q, Stuart K, Vijayakumar S, Chen AM. Postoperative radiation therapy for head and neck cancer in the setting of orocutaneous and pharyngocutaneous fistula. Am J Clin Oncol 2011; 34: 276-280.

95. Li B, Shi XB, Nori D, Chao CK, Chen AM, Valicenti R, de Vere White R. Down-regulation of

microRNA 106b is involved in p21-mediated cell cycle arrest in response to radiation in prostate cancer cells. Prostate 2011; 71: 567-574.

96. Chen AM, Li BQ, Lau DH, Farwell DG, Luu Q, Newman K, Vijayakumar S. Evaluating the role of prophylactic gastrostomy tube placement prior to definitive chemoradiotherapy for head and neck cancer. Int J Radiat Oncol Biol Phys 2010; 78: 1026-1032.

97. Chen AM, Li BQ, Jennelle RL, Lau DH, Yang CC, Courquin J, Vijayakumar S, Purdy JA.

Late esophageal toxicity after radiation therapy for head and neck cancer. Head Neck 2010; 32: 178-183.

98. Chen AM, Farwell DG, Luu Q, Chen LM, Vijayakumar S, Purdy JA. Misses and near misses

among patients treated postoperatively with radiation therapy for head and neck cancer: A comparison of intensity-modulated and conventional radiation therapy techniques in the CT simulation era. Head Neck 2010; 32: 1452-1459.

99. Chen AM, Lee NY, Yang CC, Liu T, Narayan S, Vijayakumar S, Purdy JA. Comparison of

intensity-modulated radiotherapy using helical tomotherapy and segmental multileaf collimator-based techniques for nasopharyngeal carcinoma: Dosimetric analysis incorporating quality assurance guidelines from RTOG 0225. Technol Cancer Res Treat 2010; 9: 291-8.

100. Chen AM, Sreeraman R, Mathai M, Vijayakumar S, Purdy JA. Potential of helical

tomotherapy to reduce dose to the ocular structures for patients treated for unresectable cancers of the paranasal sinus. Am J Clin Oncol 2010; 33: 595-598.

A.Chen, of 37

101. Chen AM, Garcia J, Granchi P, Bucci MK, Lee NY. Base of skull recurrences after treatment of salivary gland cancer with perineural invasion reduced by postoperative radiotherapy. Clin Otolaryngol 2010; 34: 539-545.

102. Chen AM, Breast-conserving therapy after neoadjuvant chemotherapy for locally advanced

breast cancer. Breast diseases 2010. 103. Martinez S, Beal SH, Canter R, Khatri V, Chen AM, Bold R. Disparities in the use of radiation

therapy in patients with local-regionally advanced breast cancer. Int J Radiat Oncol Biol 2010; 78: 787-792.

104. Yang CC, Liu T, Jennelle RL, Ryu JK, Vijayakumar S, Purdy JA, Chen AM. Utility of

megavoltage fan-beam CT for treatment planning in a head-and-neck cancer patient with extensive dental fillings undergoing helical tomotherapy. Med Dosim 2010; 35: 108-114.

105. Farwell DG, Rees CJ, Mouadeb DA, Allen J, Chen AM, Enepekides DJ, Belafsky PC.

Esophageal pathology in patients after treatment for head and neck cancer. Otolaryngol Head Neck Surg 2010; 143: 375-378.

106. Martinez S, Beal SH, Chen AM, Chen SL, Schneider PD. Adjuvant external beam radiation

for medullary thyroid carcinoma. J Surg Oncol 2010; 102: 175-178. 107. Chen AM, Jennelle RL, Sreeraman R, Yang CC, Liu T, Vijayakumar S, Purdy JA. Initial

clinical experience with helical tomotherapy for head and neck cancer. Head Neck 2009; 31: 1571-1578.

108. Chen AM, Jennelle RL, Grady V, Tovar A, Bowen K, Simonin P, Tracy J, McCrudden D,

Stella JR, Vijayakumar S. Prospective study of psychosocial distress for patients undergoing radiation for head and neck cancer. Int J Radiat Oncol Biol Phys 2009; 73: 187-193.

109. Stanic S, Chen AM. Post-irradiation morphea: an underrecognized complication of treatment

in breast cancer. Breast diseases 2009: 20: 320. 110. Li BQ, Li D, Lau DH, Farwell DG, Luu Q, Rocke DM, Newman K, Courquin J, Purdy JA,

Chen AM. Clinical-dosimetric measures of dysphagia including gastrostomy-tube dependence among head and neck cancer patients treated definitively by intensity-modulated radiotherapy with concurrent chemotherapy. Radiat Oncol 2009; 4: 52-60.

111. Chen AM, Daly ME, El-Sayed I, Bucci MK, Lee NY, Garcia J, Phillips TL, Eisele DW.

Patterns of failure after combined modality treatment incorporating radiation therapy for sinonasal undifferentiated carcinoma of the head and neck. Int J Radiat Oncol Biol Phys 2008; 70: 338-343.

112. Chen AM, Garcia J, Granchi PJ, Griffin A, Johnson J, Eisele DW. Late recurrence from salivary gland cancer: When does cure mean cure? Cancer 2008; 112: 340-344.

A.Chen, of 37

113. Chen AM, Garcia J, Bucci MK, Chan AS, Kaplan MJ, Singer MI, Phillips TL. Recurrent salivary gland carcinomas treated by surgery with and without intraoperative radiation therapy. Head Neck 2008; 30: 2-9.

114. Chen AM, Vaughan A, Narayan S, Vijayakumar S. Palliative radiation therapy for head and

neck cancer: Is there an optimal fractionation scheme? Head Neck 2008; 30: 1586-1591. 115. Hall WH, Guiou M, Lee NY, Dublin A, Narayan S, Vijayakumar V, Purdy JA, Chen AM.

Development and validation of a standardized method for contouring the brachial plexus: Preliminary dosimetric analysis among patients treated with IMRT for head and neck cancer. Int J Radiat Oncol Biol Phys 2008; 72: 1362-1367.

116. Perks JR, Lehmann J, Chen AM, Yang CC, Stern RL, Purdy JA. Comparison of peripheral

dose from image-guided radiaton therapy (IGRT) using kV cone beam CT to intensity-modulated radiation therapy (IMRT). Radiother Oncol 2008; 89: 304-310.

117. Straume T, Amundson SA, Blakely WF, Burns FJ, Chen AM, Dainiak N, et al. NASA

radiation biomarker workshop. Radiat Res 2008; 170: 393-405. 118. Chen AM, Chang S, Pouliot J, Sneed PK, Prados MD, Lamborn KR, Malec MK, McDermott

MW, Berger MS, Larson DA. Phase I trial of gross total resection, permanent iodine-125 brachytherapy, and hyperfractionated radiotherapy for newly diagnosed glioblastoma multiforme. Int J Radiat Oncol Biol Phys 2007; 69: 825-830.

119. Chen AM, Grekin RC, Garcia J, Bucci MK, Margolis LW. Radiation therapy for cutaneous

squamous cell carcinoma involving the parotid area lymph nodes: Dose-volume considerations. Int J Radiat Oncol Biol Phys 2007; 69: 1377-1380.

120. Chen AM, Daly ME, Bucci MK, Xia P, Akazawa C, Quivey JM, Weinberg V, Garcia J, Lee

NY, Kaplan MJ, El-Sayed I, Eisele DW, Fu KK, Phillips TL. Carcinomas of the paranasal sinuses and nasal cavity treated at a single institution over the course of five decades: Are we making improvement? Int J Radiat Oncol Biol Phys 2007; 69: 141-147.

121. Chen AM, Granchi PJ, Garcia J, Bucci MK, Eisele DW. Local-regional recurrence after

surgery without postoperative irradiation for carcinomas of the major salivary glands: Implications for adjuvant therapy. Int J Radiat Oncol Biol Phys 2007; 67: 982-987.

122. Chen AM, Bucci MK, Singer MI, Garcia J, Kaplan MJ, Chan AS, Phillips TL. Intraoperative

radiation therapy for recurrent head-and-neck cancer: The UCSF Experience. Int J Radiat Oncol Biol Phys 2007; 67: 122-129.

123. Chen AM, Bucci MK, Granchi PJ, Garcia J, Lee NY, Fu KK, Eisele DW. Patterns of nodal

relapse after surgery and postoperative radiation therapy for carcinomas of the major and minor salivary glands: What is the role of elective neck irradiation? Int J Radiat Oncol Biol Phys 2007; 67: 988-994.

A.Chen, of 37

124. Chen AM, Garcia J, Bucci MK, Quivey JM, Eisele DW. The role of postoperative radiation therapy in carcinoma ex pleomorphic adenoma of the parotid gland. Int J Radiat Oncol Biol Phys 2007; 67: 138-143.

125. Daly ME, Chen AM, Bucci MK, El-Sayed I, Xia P, Kaplan MJ, Eisele DW. Intensity-

modulated radiation therapy for malignancies of the nasal cavity and paranasal sinuses. Int J Radiat Oncol Biol Phys 2007; 67: 151-157.

126. Chen AM, Jahan TM, Jablons DM, Garcia J, Larson DA. Risk of cerebral metastasis and

neurological death after complete pathological response to neoadjuvant therapy for locally advanced non-small cell lung cancer: Clinical implications for the subsequent management of the brain. Cancer 2007; 109: 1668-1675.

127. Chen AM, Bucci MK, Quivey JM, Garcia J, Eisele DW, Fu KK. Long-term outcome of

patients treated by radiation therapy alone for salivary gland carcinomas. Int J Radiat Oncol Biol Phys 2006; 66(4): 1044-1050.

128. Chen AM, Garcia J, Bucci MK, Quivey JM, Eisele DW. Recurrent pleomorphic adenoma of

the parotid gland: Long-term outcome of patients treated with radiation therapy. Int J Radiat Oncol Biol Phys 2006; 66(4): 1031-1035.

129. Chen AM, Bucci MK, Weinberg V, Garcia J, Quivey JM, Schechter NR, Phillips TL, Fu KK,

Eisele DW. Adenoid cystic carcinoma of the head and neck treated by surgery with or without postoperative radiation therapy: Prognostic features of recurrence. Int J Radiat Oncol Biol Phys 2006; 66(1): 152-159.

130. Huang E, Strom EA, Perkins GH, Oh JL, Chen AM, Meric-Bernstein F, Hunt KK, Sahin AA,

Hortobagyi GN, Buchholz TA. Comparison of local-regional recurrence after mastectomy or breast conservation therapy for patients treated with neoadjuvant chemotherapy stratified according to a prognostic index score. Int J Radiat Oncol Biol Phys 2006; 66(2): 352-357.

131. Chen AM, Meric-Bernstam F, Hunt KK, Thames HD, Outlaw ED, Strom EA, McNeese MD,

Kuerer HM, Ross MI, Singletary SE, Ames FC, Feig BW, Sahin AA, Perkins GH, Babiera G, Hortobagyi GN, Buchholz TA. Breast conservation after neoadjuvant chemotherapy: A prognostic index for clinical decision-making. Cancer 2005; 103(4): 689-695.

132. Chen AM, Meric-Bernstam F, Hunt KK, Buchholz TA. Patient selection for breast

conservation after neoadjuvant chemotherapy: Developing a prognostic index. Am J Clin Oncol Rev 2005; 4(6): 2-6.

133. Chen AM, Meric-Bernstam F, Hunt KK, Thames HD, Oswald MJ, Outlaw ED, Strom EA,

McNeese MD, Kuerer HM, Ross MI, Singletary SE, Ames FC, Feig BW, Sahin AA, Perkins GH, Schechter NR, Hortobagyi GN, Buchholz TA. Breast conservation after neoadjuvant chemotherapy: The M.D. Anderson Cancer Center experience. J Clin Oncol 2004; 22(12): 2303-2312.

A.Chen, of 37

134. Chen AM, Hunt KK, Meric-Bernstam F, Buchholz TA. Neoadjuvant chemotherapy to permit breast conservation therapy for locally advanced breast cancer. Am J Clin Oncol Rev 2004; 3(12): 10-15.

135. Chen AM, Haffty BG, Lee CH. Local recurrence of breast cancer after breast conservation

therapy in patients examined by means of stereotactic core needle biopsy. Radiology 2002; 225(3): 707-712.

136. Chen AM, Fan GF, Buchholz TA. Internal mammary node lymphoscintigraphy and biopsy in

breast cancer. Wom Oncol Rev 2002; 2(4): 453-454. 137. Chen AM, Obedian E, Haffty BG. Breast-conserving surgery and radiation therapy in the

setting of collagen vascular disease. Cancer J 2001; 7(6): 480-491. 138. Daly ME, Chen AM. Integration of radiation therapy in the management of

esthesioneuroblastoma: Evidence and current controversies. Skull base (in press).

139. Chen AM, Beron P, Wong D, Rosove MH, Steinberg ML, Kupelian PA, Daly ME. De-escalated chemoradiation strategies for human papillomavirus-associated oropharyngeal cancer. Lancet Oncol (in press).

140. Chen AM, Raghavan G, Cao M, Mikaielian A, Sepahdari A. Comparison between CT- and MRI-derived head and neck cancer target volumes using an integrated MRI- tri-60Co teletherapy device. Radiology (in press).

141. Chen AM, Kupelian PA, Wang PC, Steinberg ML. Development of a radiation oncology-specific registry for research and quality assurance: A clinical-workflow solution. J Clin Oncol (in press).

142. Shaverdian N, Hegde J, Felix C, Steinberg ML, Chen AM. Patient perspectives and treatment regret in the setting of de-escalation therapy for human papillomavirus-positive oropharyngeal cancer. Oncologist (in press).

143. Li BQ, Qi LH, Lau DH, Beckett LA, Chen AM. Prognosis among Asian Americans treated by

chemoradiation for nasopharyngeal carcinoma. Head Neck (in press).

144. Velez MA, Veruttipong D, Wang PC, Abemayor E, St. John M, TenNapel M, Chen AM. Prognostic significance of FDG-PET metabolic tumor parameters for patients treated by re-irradiation for local-regionally recurrent head and neck cancer. Am J Otolaryngol (in press).

145. Rash D, Farwell DG, Donald P, Luu Q, Chen AM. Human papillomavirus negative-associated oropharyngeal carcinoma: Clinical outcomes by treatment modality. ENT Journal (in press).

146. Chen AM, Yoshizaki T, Hsu S, Cao M. Adaptive radiotherapy improves the therapeutic ratio in the setting of head and neck cancer. Radiother Oncol (under review).

A.Chen, of 37

147. Rwigema JC, Lee NY, Heron D, Chen AM. Variability in treatment technique for the re-irradiation of head and neck cancer. Int J Radiat Oncol Biol Phys (under review).

148. Hegde J, Shaverdian N, Felix C, Veruttipong D, Wang PC, Rao S, Daly ME, Chen AM. Functional outcomes after de-escalated chemoradiation for human papillomavirus-positive oropharyngeal cancer. J Clin Oncol (under review).

149. Hess CB, Harandi NK, Yarborough M, Steinberg MS, Chen AM. Current attitudes of radiation

Oncology physicians regarding ethical dilemmas in clinical practice: Findings from a national patterns of care survey. Int J Radiat Oncol Biol Phys (under review).

150. Sood SS, McClinton C, Badkul R, Aguilera N, Wang F, Chen AM. Brachial plexopathy after stereotactic body radiotherapy for apical lung cancer: Dosimetric analysis and preliminary clinical outcomes. Int J Radiat Oncol Biol Phys (under review).

151. Sood SS, Shen X, Wang F, Chen AM. Ultra-central thoracic re-irradiation using stereotactic body radiotherapy for recurrent non-small-cell lung cancer tumors: Preliminary toxicity and efficacy outcomes. Int J Radiat Oncol Biol Phys (under review).

152. Meshman J, Wang PW, St. John M, Chen AM. Prognostic significance of p16 in larynx

cancer treated by radiation therapy. Head Neck (under review).

153. Marconi D, Carvahlo A, Chen AM. Superficial x-ray therapy for non-melanoma skin cancer of the head and neck: comparative analysis of H-Zone versus non H-Zone lesions. Int J Radiat Oncol Biol Phys (under review).

154. Velez M, Wang PW, Lee SP, Chen AM. Patterns of failure by re-irradiation technique.

Radiother Oncol (under review).

155. Moalikyar O, Daly ME, Farwell DG, Donald P, Chen AM. Patient-reported and physician-rated functional outcomes among patients treated by radiation therapy for human papillomavirus oropharyngeal cancer. Head Neck (under review).

156. Wang PC, Meshman J, Abemayor E, St. John M, Mendelsohn A, Chen AM. Immune

parameters mediate outcome for human papillomavirus associated head and neck cancer. Int J Radiat Oncol Biol Phys (under review).

157. Wang F, Sood SS, Yap W, Madnan R, TenNapel M, Shen X, Huang C, Chen AM. Early-stage lung adenocarcinoma treated with stereotactic body radiotherapy: Prognostic factors for treatment outcomes. Int J Radiat Oncol Biol Phys (under review).

158. Raghavan G, Kishan A, Yoshizaki T, Cao M, Chen AM. Modeling changes in tumor volume

and organs-at-risk using on-line magnetic resonance imaging. Radiology (under review).

A.Chen, of 37

BOOK CHAPTERS 1. Chen AM, Ryu JK, Donald P, Colevas A. Cancers of the nasal cavity and paranasal sinuses, in

Leibel SA, Phillips TL (ed): Textbook of Radiation Oncology. Philadelphia, PA, Saunders, 2011.

2. Chen AM, Grekin RC, Margolis LW. Skin cancer, in Leibel SA, Phillips TL (ed): Textbook of

Radiation Oncology. Philadelphia, PA, Saunders, 2011. 3. Chen AM, Gregoire V, Chao KS. Image-guided radiotherapy for head and neck cancer, in

Levitt SH (ed): Technical Basis of Radiation Therapy: Practical Clinical Applications (in process). New York, NY, Springer, 2011.

4. Chen AM, Vijakakumar S, Thomas CR (ed). Prostate Cancer (Radiation Medicine Rounds

Series). Elsevier, Philadelphia, PA, 2011. 5. Chen AM, Purdy JA. Image-guidance in the radiotherapeutic management of head and neck

cancer, in Tischer R, Heron D, Thomas CR (ed): Head and Neck Cancer. Elsevier, Philadelphia, PA, 2011.

6. Chen AM, Yao M. Salivary gland cancers, in Machtay M (ed): Head and Neck Cancer.

Elsevier, Philadelphia, PA, 2013 (in press). 7. Chen AM, Yao M. Cancers of the temporal bone and external ear canal, in Machtay M (ed):

Head and Neck Cancer. Elsevier, Philadelphia, PA 2013 (in press). 8. Unger K, Riaz N, Chen AM, Lee N. Oral cavity cancer, in Lee N (ed); Pocket Guide to

Radiation Oncology, Springer, New York, NY, 2012. 9. Riaz N, Chen AM, Lee N. Unknown primary cancer of the head and neck, in Lee N (ed);

Pocket Guide to Radiation Oncology, Springer, New York, NY 2012. 10. Lee NY, Chen AM: Cancers of the nasal cavity and paranasal sinuses, in Harrison LB,

Sessions RB, Hong WK, Mendenhall W, Medina J (ed): Head and Neck Cancer: A Multidisciplinary Approach. New York, NY, Lippincott Raven, 2008.

11. Chen AM, Margolis LW, Bevan A, Schechter NR, Quivey JM, Park CC: Early-stage breast

cancer and ductal carcinoma in-situ, in Hansen EK, Roach M (ed): Handbook of Radiation Oncology. New York, NY, Springer, 2006.

12. Chen AM, Margolis LW, Bevan A, Schechter NR, Quivey JM, Park CC: Locally-advanced

breast cancer, in Hansen EK, Roach M (ed): Handbook of Radiation Oncology. New York, NY, Springer, 2006.

13. Chen AM, Schechter NR: Tumors of the major and minor salivary glands, in Hansen EK,

Roach M (ed): Handbook of Radiation Oncology. New York, NY, Springer, 2006.

A.Chen, of 37

INVITED TALKS/PRESENTATIONS (PARTIAL LISTING)

1. University of Texas- San Antonio, Department of Radiation Oncology, “Evolving paradigms in oropharyngeal cancer,” [visiting professorship], 5/2017

2. Henry Ford Health System, Cancer Center, Detroit- MI, “Current controversies in larynx preservation,” [visiting professorship], 5/2017

3. Wayne State University, Department of Radiation Oncology, “Clinical trials in head and neck cancer radiation oncology,” [visiting professorship], 5/2017

4. University of Kansas, Lung and head and neck cancer symposium, Overland Park, KS, “Evolving strategies in the management of oropharyngeal cancer: the role of HPV,” [oral presentation], 2/2017

5. Radiological Society of North America, Chicago, IL, “Evaluation of radiation response after treatment for head and neck cancer,” [oral presentation], 12/2016

6. Kansas City Chiefs, Honorary “First-pass” Coin-toss Participant, “Advances in cancer care,” [honorary speaker], 11/2016

7. American Society for Radiation Oncology, Boston, MA, “Meet the professor dinner reception,” 9/2016

8. American Society for Radiation Oncology, Boston, MA, “Review of radiotherapeutic techniques for salivary gland cancer,” [oral presentation], 9/2016

9. Association of Residents in Radiation Oncology, Boston, MA, “Meet the professor: Networking reception,” [invited professor], 9/2016

10. Hollywood Presbyterian Hospital, Grand Rounds, Los Angeles, CA, “Magnetic resonance

safety for the primary care physician,” [oral presentation], 9/2016

11. Multidisciplinary Head and Neck Cancer Symposium, Scottsdale, AZ, “Radiation techniques for oral cancer,” [oral presentation], 2/2016

12. NRG Oncology, Atlanta, GA, “Anti-PD-1 therapy plus/minus stereotactic body radiotherapy for oligo-metastasis,” [oral presentation], 1/2016

13. Stanford University, Department of Radiation Oncology, Palo Alto, CA, “Re-irradiation for recurrent head and neck cancer: Challenges and pitfalls,” [visiting professorship], 11/2015

14. University of Arkansas Medical School, Little Rock, AR, “De-escalation strategies for HPV-associated head and neck cancer,” [visiting professorship], 11/2015

A.Chen, of 37

15. American Society for Radiation Oncology, San Antonio, TX, “Re-irradiation for recurrent head and neck cancer: Who, why, how, and how much?,” [oral presentation], 10/2015

16. Emory University- Winship Comprehensive Cancer Center, Grand Rounds, Atlanta, GA, 10/15, “Salvage therapies for recurrent head and neck cancer: The role of re-irradiation,” [oral presentation], 10/2015

17. American Society for Radiation Oncology, San Antonio, TX, “Prognostic factors in head and neck cancer,” [oral presentation], 10/2015

18. UCLA Chair’s Course, “Ethics in Human Research: From Helsinki to Tuskegee and Everything in Between,” [oral presentation], 8/2015

19. Cedars-Sinai Medical Center, Los Angeles, CA, “Human papillomavirus-associated head and neck cancer: An emerging epidemic,” [oral presentation], 8/2015

20. Kaiser Permanent Medical Center- Los Angeles, Grand Rounds, “Re-irradiation for recurrent head and neck cancer,” [oral presentation], 7/2015

21. Hollywood Presbyterian Hospital, Grand Rounds, Los Angeles, CA, “Radiation safety for the primary care physician,” [oral presentation], 7/2015

22. American Society of Clinical Oncology, Chicago, IL, “Radiation techniques and outcomes for oral cavity cancer,” [oral presentation], 6/2015

23. San Fernando Valley Continuing Medical Education Forum, Van Nuys, CA, “Head neck cancer for the primary care physician,” [oral presentation], 5/2015

24. American Society for Radiation Oncology, State-of-the-Art Technology Meeting, Las Vegas, NV, “Re-irradiation for recurrent head and neck cancer: Challenges and Opportunities,” [oral presentation], 4/2015

25. ACRO/Southern California 2nd Annual Radiation Oncology Education Symposium, “Welcome address,” [oral presentation], 4/2015

26. Los Angeles Radiologic Society, Pasadena, CA, “Head and neck cancer radiotherapy,” [oral presentation], 2/2015

27. UCLA Resident/Fellow Wellness Retreat, Laguna Beach, CA, “Professionalism and conflict resolution in the workplace,” [oral presentation], 1/2015

28. Taiwanese Society for Radiation Oncology, Tainan, Republic of China, “Emerging role of human papillomavirus in treatment decision-making for head and neck cancer,” [oral presentation], 12/2014

A.Chen, of 37

29. Radiological Society of North America, Chicago, IL, “Advanced imaging technologies for radiation therapy,” [oral presentation], 11/2014

30. UCLA-Brazil Collaborative Conference on Oncology, Barretos, Brazil “Radiation techniques for head and neck cancer,” [oral presentation], 11/2014

31. International Federation of Head and Neck Oncologic Societies/ American Head and Neck Society Meeting, New York, NY, “Radiation de-escalation for human papillomavirus-positive oropharyngeal cancer,” [oral presentation], 6/2014

32. American Society for Radiation Oncology, State-of-the-Art Technology Meeting, San Antonio, TX, “Practical essentials of intensity-modulated radiotherapy planning and delivery for head and neck cancer,” [oral presentation], 5/2014

33. American Society for Radiation Oncology, State-of-the-Art Technology Meeting, San Antonio, TX, “Practical essentials of image-guidance and adaptive radiotherapy for head and neck cancer,” [oral presentation], 5/2014

34. American Society for Radiation Oncology, State-of-the-Art Technology Meeting, San

Antonio, TX, “Head and neck cancer case panel discussion,” [chair], 5/2014

35. ACRO/Southern California 2nd Annual Radiation Oncology Education Symposium, “Welcome address,” [oral presentation], 4/2014

36. UCLA Medical Student Research Symposium, “Radiation Oncology as a Career,” [oral presentation], 3/2014

37. International Association for the Study of Lung Cancer, Santa Monica, CA, “PARP inhibitors and lung cancer: Update of SWOG S1206 using chemoradiotherapy with ABT-888,” [oral presentation], 2/2014

38. Cedars Sinai-Samuel Oschin Comprehensive Cancer Center, Department of Radiation

Oncology, Grand Rounds, “Human papillomavirus-associated head and neck cancer: An evolving paradigm” [oral presentation], 11/2013

39. American Society for Radiation Oncology, Atlanta, GA “HPV-positive head and neck cancer: Competing risk factors for death” [oral presentation], 10/2013

40. Los Angeles Community Head/Neck Cancer Survivors and Support Group, “Quality of life and depression after treatment for head/neck cancer,” [oral presentation], 10/2013

41. University of California, Irvine, Department of Radiation Oncology, Grand Rounds, “Human papillomavirus-associated head and neck cancer: An evolving paradigm” [oral presentation], 9/2013

A.Chen, of 37

42. Twenty-first Century Oncology-Palm Springs, Department of Radiation Oncology, Grand Rounds, “Human papillomavirus-associated head and neck cancer: An evolving paradigm” [oral presentation], 8/2013

43. Journal of American Medical Association (JAMA) Multimedia Video, Los Angeles, CA

“Depression among long-term survivors of head and neck cancer treated with radiation therapy,” 8/2013

44. UC Davis Medical Student Wellness Retreat, Tiburon, CA, “Professionalism and stress management in the workplace,” 5/2013

45. American Radium Society, Scottsdale, AZ, “Laryngeal and esophageal dysfunction after head and neck radiotherapy,” 4/2013

46. Peace Health- Continuing Medical Education, Bellingham, WA, “Changing paradigms in

the management of head and neck cancer: the role of HPV,” [keynote speaker], 3/2013 47. American Society for Radiation Oncology- Cancer Imaging and Research Symposium,

Orlando, FL, “Management of the post-radiation neck with PET: neck dissection versus observation,” [oral presentation], 2/2013

48. International Association for the Study of Lung Cancer, Santa Monica, CA, “PARP

inhibitors and lung cancer: Update of SWOG S1206 using chemoradiotherapy with ABT-888,” [oral presentation], 2/2013

49. Capitol Public Radio (NPR News), Sacramento, CA, “HPV-related head and neck cancer: a growing epidemic,” [radio interview], 1/2013

50. Accuray Advancing Radiation Oncology Conference, Dallas, TX, “Practical case discussion

with Tomotherapy and Cyberknife,” [panelist], 11/2012

51. Accuray Advancing Radiation Oncology Conference, Dallas, TX, “Tomotherapy for synchronous primaries of the head and neck,” [oral presentation], 11/2012

52. American Society for Radiation Oncology, Boston, MA, “Improved clinical outcomes with

image-guidance for head and neck cancer,” [oral presentation], 10/2012

53. University of California, Davis, Comprehensive Cancer Center, Department of Medical Oncology, “Human papillomavirus-related head and neck cancer: Changing paradigms,” [oral presentation], 9/2012

54. American Head and Neck Society, Toronto, Canada, “Target volume design for head and

neck cancer,” [oral presentation], 7/2012

55. American Head and Neck Society, Toronto, Canada, “Management of the post-irradiation neck,” [panelist], 7/2012

A.Chen, of 37

56. University of Southern California, Department of Radiation Oncology, “Developing a

research infrastructure in the modern era of radiation oncology: Challenges and pitfalls,” [oral presentation], 6/2012

57. University of California, Los Angeles, Department of Radiation Oncology, “Developing a research infrastructure in the modern era of radiation oncology: Challenges and pitfalls,” [oral presentation], 6/2012

58. American Radium Society, Las Vegas, NV, “Racial disparities in the use of organ-

preservation for laryngeal cancer” [oral presentation], 5/2012

59. University of California, Davis, Medical Center- Quality Improvement Symposium, “Implementation of a long-term smoking cessation clinic in the Cancer Center,” [oral presentation], 4/2012

60. Multidisciplinary Head and Neck Cancer Symposium, Phoenix, AZ, “Quality of life improvement with intensity-modulated radiotherapy among survivors of head and neck cancer” [oral press release], 1/2012

61. University of California, Davis, Department of Otolaryngology, Grand Rounds, “Human

papillomavirus-associated head and neck cancer: An evolving paradigm,” [oral presentation], 1/2012

62. University of California, Davis, Primary Care Symposium, Auburn, CA, “Emerging

applications for stereotactic body radiotherapy?” [oral presentation], 12/11

63. American Society for Radiation Oncology, Miami, FL, “Targeted therapies for head and neck cancer” [session moderator], 10/2011

64. Peace Health- Continuing Medical Education, Seattle, WA “Human papillomavirus-

associated head and neck cancer: An evolving paradigm,” [oral presentation], 10/2011

65. University of California, Advances in Oncology Symposium, Sacramento, CA, “Management of locally advanced lung cancer,” [oral presentation], 9/2011

66. University of California, Davis, Primary Care Symposium, Folsom, CA, “Stereotactic body

radiotherapy for early-stage lung cancer: A new standard?” [oral presentation], 9/2011

67. California New Technologies Forum, Los Angeles, CA, “Stereotactic body radiotherapy for lung cancer: A new standard?” [oral presentation], 6/2011

68. Association of Northern California Oncologists, San Francisco, CA, “Emerging applications for stereotactic body radiotherapy,” [oral presentation], 6/2011

A.Chen, of 37

69. Tomotherapy User’s Conference, Charleston, SC, “How does helical tomotherapy affect the therapeutic ratio for nasopharyngeal cancer?,” [oral presentation], 3/11

70. American Society for Therapeutic Radiology and Oncology, San Diego, CA, “Image-guidance to reduce PTV margins for head and neck cancer,” [oral presentation], 11/2010

71. American Society for Therapeutic Radiology and Oncology, San Diego, CA, “Prospective

study of clinical-dosimetric factors predictive of brachial plexopathy after head and neck cancer,” [oral presentation], 11/2010

72. UCSF/UC Davis Annual Thoracic Conference, San Francisco, CA, “New strategies in the

management of locally advanced non-small cell lung cancer,” [oral presentation], 11/2010

73. University of California, Davis, Department of Surgery, Grand Rounds, “Is stereotactic body radiation therapy a feasible alternative to surgery for early-stage lung cancer?” [oral presentation], 11/2010

74. International Federation of Head and Neck Oncologic Societies, Seoul, South Korea,

“Image-guided radiotherapy for head and neck cancer,” [oral presentation], 6/2010

75. World Cancer Congress, Singapore, "Advances in radiation therapy for head and neck cancer," [oral presentation], 6/2010

76. Radiation Therapy Oncology Group, Tampa, FL, “Does IMRT increase the incidence of

brachial pleoxopathy compared to conventional treatment?” [oral presentation], 1/2010

77. University of California, Davis, Department of Internal Medicine, Grand Rounds, “Current status of stereotactic body radiation therapy,” [oral presentation], 11/2009

78. American Society for Therapeutic Radiology and Oncology, Chicago, IL, “Brachial plexopathy after head and neck cancer,” [oral presentation], 11/2009

79. American Society for Therapeutic Radiology and Oncology, Chicago, IL, “Overstaging of

cartilage invasion by multi-detector CT scan for laryngeal cancer and its potential effect on the use of organ preservation with chemoradiation,” [oral discussion], 11/2009

80. UCSF/UC Davis Annual Thoracic Conference, San Francisco, CA, “Locally advanced non-

small cell lung cancer,” [oral presentation], 11/2009

81. University of California, Davis, Cancer Symposium, Sacramento, CA “Translational research in head and neck cancer: Current happenings at UC Davis [oral presentation],” 9/2009

82. University of California, Davis, Cancer Center 10th Annual Advances in Oncology

Conference, Sacramento, CA “Lung cancer,” [oral presentation], 9/2009

A.Chen, of 37

83. San Francisco Radiation Oncology Conference, San Francisco, CA, “Clinical applications with tomotherapy,” [oral presentation], 4/2009

84. University of California Davis, Radiation Biology-Oncology “Crosstalk” Seminar,

“Biomarkers and translational research in head and neck cancer,” [oral presentation], 1/2009

85. Association of Northern California Oncologists, San Francisco, CA, “Radiation oncology highlights from the San Antonio Breast Cancer Symposium,” [oral presentation], 1/2009

86. Radiological Society of North America, Chicago, IL, “Daily kilovoltage CT imaging in the

head and neck documents significant volume change and positional shifts during postoperative IMRT,” [oral presentation], 12/2008

87. North America Radiological Society, Chicago, IL, “Comparison of brachial plexus dose

using conventional 3-field versus IMRT treatment planning,” [oral presentation], 11/2008

88. UCSF/UC Davis Thoracic Oncology Conference, San Francisco, CA, “Locally-advanced lung cancer,” [oral presentation], 11/2008

89. Visiting Professor, University of Mississippi Medical Center, Jackson MI, “Applications of

PET technology in the management of head and neck cancer,” [oral presentation], 10/2008

90. KTVU News, San Francisco, CA “HPV-related head and neck cancer,” [television interview], 10/2008

91. Department of Otolaryngology, University of California, Davis, School of Medicine, Grand

Rounds, “Advances in head and neck radiation oncology,” [oral presentation], 7/2008

92. NASA Radiation Biomarker Workshop, Mountain View, CA, “Clinical utility of biomarker research in head and neck cancer: From bench to bedside [oral presentation],” 10/2007

93. Visiting lecturer, City of Hope National Medical Center, Duarte, CA, “Neoadjuvant chemotherapy to expand the use of the breast conservation [oral presentation],” 7/2006

94. American Radium Society, Napa, CA, “Breast conservation after neoadjuvant

chemotherapy: A prognostic index for clinical decision-making [oral presentation],” 5/2004

95. San Antonio Breast Cancer Symposium, San Antonio, TX, “Breast conservation after neoadjuvant chemotherapy: The University of Texas- M.D. Anderson Cancer Center experience [oral presentation],” 12/2003

96. Kaiser Permanente, Department of Urology, Grand Rounds, “Radiotherapy in prostate

cancer [oral presentation], 2/2002

97. Kaiser Permanente, Department of Internal Medicine, Grand Rounds, “Radiation oncology emergencies [oral presentation], 1/2002

A.Chen, of 37

98. American Radium Society, San Diego, CA, “Breast-conserving surgery and radiation

therapy in the setting of collagen vascular disease [oral presentation],” 5/2001

99. American Roentgen Ray Society, Seattle, CA, “Local recurrence of breast cancer after breast conservation therapy in patients examined by means of stereotactic core needle biopsy [oral presentation],” 5/2001

100. United States Department of Health and Human Services (United States Public Health Service), Indian Health Service Hospital, Northern Cheyenne Reservation, WY, “Cancer screening for the primary care physician in the rural community: An overview of the costs and benefits,” [oral presentation], 12/2001

SELECTED ABSTRACTS (PARTIAL LISTING)

1. Hegde J, Felix C, Hsu S, Basehart V, Steinberg M, Chen AM. Functional outcomes and quality of life after de-escalated chemoradiation for human papillomavirus-positive oropharyngeal cancer. ASTRO 2017

2. Melo R, Wang PC, Meshman J, Abemayor E, St. John M, Chen AM. Evaluating the role of surveillance imaging in asymptomatic patients after definitive radiation for head and neck cancer. ASTRO 2017

3. Velez MA, Veruttipong D, Wang PC, Abemayor E, St. John M, TenNapel M, Chen AM.

Prognostic significance of FDG-PET metabolic tumor parameters for patients treated by re-irradiation for local-regionally recurrent head and neck cancer. ASTRO 2017

4. Badkul R, Kile L, Saleh H, Lominska CE, Chen AM. Dosimetric comparison of coplanar volumetric modulated arc therapy (VMAT) and non-coplanar intensity modulated radiotherapy for pancreatic cancer. ASTRO 2017

5. Doke K, Chen AM, King S, Aguilera N, Lominska CE. Differences in the temporal patterns of volumetric regression and recovery for spared and in-field submandibular glands among patients treated by radiation for oropharynx cancer. ASTRO 2017

6. Ganju RG, Chen AM, Mitchell MP. Analysis of the utilization of hypofractionated regimens for early stage breast cancer at a tertiary care cancer center and its community-based affiliates. ASTRO 2017

7. Ganju RG, Shen X, Wang F, Chen AM, TenNapel M, Lominska C. Outcomes of stereotacic radiosurgery for brain metastasis from metastatic melanoma in the immunotherapy era. ASTRO 2017

8. Ganju RG, TenNapel M, Chen AM, Hoover A. Prognostic significance of sarcopenia for patients treated by radiation for uterine cancer. ASTRO 2017

A.Chen, of 37

9. Hoover AC, Ganju R, TenNapel M, Tawfik O, Chen AM. Undifferentiated endometrial

carcinomas: clinic-pathological characteristics and patterns of care. ASTRO 2017

10. Hoover AC, Ganju R, TenNapel M, Chen AM. Utility of body mass index in predicting tolerance to radiation in locally advanced cervical cancer. ASTRO 2017

11. Sood SS, McClinton C, Badkul R, Aguilera N, Wang F, Chen AM. Brachial plexopathy after stereotactic body radiotherapy for apical lung cancer: Dosimetric analysis and preliminary clinical outcomes. ASTRO 2017

12. King S, Sood SS, TenNapel M, Badkul R, Aguilera N, Wang F, Chen AM. Evaluation of gross tumor volume changes prior to the first delivered fraction in primary and metastatic lung tumors treated by stereotactic body radiotherapy. ASTRO 2017

13. Sood SS, Shen X, Wang F, Chen AM. Ultra-central thoracic re-irradiation using stereotactic body radiotherapy for recurrent non-small-cell lung cancer tumors: Preliminary toxicity and efficacy outcomes. ASTRO 2017

14. TenNapel M, Shen X, Chen AM. Clinical trial accrual patterns for radiation oncology patients at an academically-based tertiary care medical center. ASTRO 2017

15. Wang F, Sood SS, Yap W, Madnan R, TenNapel M, Shen X, Huang C, Chen AM. Early-stage lung adenocarcinoma treated with stereotactic body radiotherapy: Prognostic factors for treatment outcomes. ASTRO 2017

16. Tejwani A, Waller JG, Chen AM. Medical malpractice and adverse action cases among allied health professionals in the radiological sciences: a comparison of technological specialties. ASTRO 2017

17. Shaverdian N, Hegde J, Felix C, Steinberg ML, Chen AM. Patient perspectives and treatment regret in the setting of de-escalation therapy for human papillomavirus-positive oropharyngeal cancer. ASCO- Survivorship 2017

18. Frederick J, Chen AM, Cohen A, Mendelsohn A. Trans-oral robotic surgery for human papillomavirus-associated squamous cell carcinoma of unknown primary origin. AHNS 2017

19. Chen AM, Felix C, Wang PC, Rao S, Wong D, Daly ME. Radiation de-escalation for human

papillomavirus-positive oropharyngeal cancer: Results of a phase II trial. ASTRO 2016

20. Mihaela C, Miao J, Argris A, Chen AM, Daly ME, Decker R, Garland LL, Wang D, Kocywas M, Moon J, Kelly K, Gandara D. SWOG S1206: A dose-finding study of veliparib (ABT-888) added to chemoradiotherapy (CRT) with carboplatin (C) and paclitaxel (P) for unresectable stage III non-small cell lung cancer (NSCLC). ASCO 2016

A.Chen, of 37

21. Wang CY, Beron P, St. John M, Abemayor E, Chen AM. Second malignancies after head and neck cancer. ARS 2016

22. Frederick J, Chen AM, Cohen A, Schroeder W, Mendelsohn A. Transrobotic surgery for head and neck cancer of unknown primary origin. AHNS 2016

23. Chen AM, Hsu S, Felix C, Wang J, Basehart V. Patient versus physician-reported toxicities among survivors of head and neck cancer after chemoradiation: Prospective evaluation of screening methodologies. ASCO- Survivorship 2016

24. Chen AM, Wang J, Basehart V, Steinberg ML, Kupelian PA. Development of a radiation oncology-specific prospective data registry for clinical research and quality improvement: A clinical workflow-based solution. ASCO- Quality Care 2016

25. Chen AM, Safa A, Kupelian PA, Steinberg ML. Implementation of a virtual chart rounds for community-university collaboration to improve quality of care in radiation oncology. ASCO- Quality Care 2016

26. Wang PC, Meshman J, Abemayor E, St. John M, Mendelsohn A, Chen AM. Low pre-treatment lymphocyte and circulating white blood cell count predict for disease-specific death among patients with HPV-positive squamous cell carcinoma of the head and neck treated by radiation therapy. H&N Multidisciplinary 2016

27. Meshman J, Wang PC, Abemayor E, St. John M, Mendelsohn A, Wong D, Chin R, Bhuta S, Chen AM. Incidence of long-term gastrostomy feeding-tube dependence by primary treatment modality for patients with squamous cell carcinoma of the head and neck. H&N Multidisciplinary 2016

28. Meshman J, Wang PC, Abemayor E, St. John M, Mendelsohn A, Wong D, Chin R, Bhuta S, Chen AM. Human papillomavirus positive squamous cell carcinoma of the oropharynx: A single-institutional experience. H&N Multidisciplinary 2016

29. Meshman J, Wang PC, Abemayor E, St. John M, Mendelsohn A, Chin R, Bhuta S, Chen AM. Prognostic significance of p16 in squamous cell carcinoma of the larynx. H&N Multidisciplinary 2016

30. Rwigema JC, Thomas D, Cao M, Yoshizaki T, Chen AM. Intra-fraction tracking with real-time MR-guided radiotherapy for head and neck cancer. H&N Multidisciplinary 2016

31. Rwigema JC, Lee N, Heron D, Chen AM. Salvage therapy for recurrent head and neck cancer: A national survey of practice patterns. H&N Multidisciplinary 2016

32. Raghavan G, Kishan A, Yoshizaki T, Cao M, Chen AM. Modeling changes in tumor volume

and organs-at-risk using on-line magnetic resonance imaging. H&N Multidisciplinary 2016

A.Chen, of 37

33. Velez M, Rwigema JC, Abemayor E, St. John M, Chin R, Chen AM. Re-irradiation for recurrent and new primary head and neck cancer: Comparison of treatment modalities. H&N Multidisciplinary 2016

34. Cao M, Yoshizaki T, Kupelian P, Low D, Chen AM. Feasibility of MRI-guided radiotherapy for Head and Neck Cancers: A dosimetric comparison between Intensity Modulated Tri-Cobalt-60 teletherapy and LINAC Based radiotherapy. H&N Multidisciplinary 2016

35. Chen AM, Felix C, Garst J, Hsu S, Wang PC, Basehart V. Differences in patient- versus physician-reported late toxicities among survivors of head and neck cancer after chemoradiation: Prospective evaluation of screening methodologies. ASCO-QOL 2016

36. Hess C, Yarborough M, Steinberg ML, Chen AM. Current attitudes of radiation oncology physicians regarding ethical dilemmas in clinical practice: Findings from a national survey of academic versus community-based physicians. ASTRO 2015

37. Marconi DG, Resende B, Rauber E, Soares P, Junior JF, Carvalho A, Kupelian P, Chen AM. Superficial x-ray therapy for non-melanoma skin cancer of the head and neck: comparative analysis of H-Zone versus non H-Zone lesions. ASTRO 2015

38. Rwigema JC, Nguyen D, Heron DE, Chen AM, Lee P, Wang PC, Vargo JA, Low DA,Huq

MS, Tenn S, Steinberg ML, Kupelian P, Sheng K. 4pi noncoplanar stereotactic body radiotherapy for head and neck cancer: potential to improve local control and late toxicity. ASTRO 2014

39. Marconi DG, Resende B, Rauber E, Soares P, Junior JF, Carvalho A, Kupelian P, Chen AM. Head and neck non-melanoma skin cancer treated by orthovoltage radiation: An analysis of 1021 cases. ASTRO 2014

40. Hess C, Yarborough M, Steinberg ML, Chen AM. Current attitudes of practicing physicians

regarding ethical dilemmas in radiation oncology: Findings from a national survey. ASTRO 2014

41. Moalikyar O, Chen AM, Young J, Donald P, Luu Q, Farwell DG, Daly ME. Adjuvant

radiation therapy for sarcomas of the head and neck. ASTRO 2014

42. Hayes JT, Chen AM, Daly ME. Risk of pneumonitis after stereotactic body radiotherapy for non-small-cell lung cancer after prior anatomic resection. ASTRO 2014

43. Harris B, Biron VL, Donald P, Farwell D, Luu QC, Bewley AF, Chen AM, Daly ME. Primary surgery versus radiation for hypopharyngeal cancer: A single-institutional analysis. IFHNOS 2014

44. Gomez CL, Chen AM. Implementation of an anti-constipation prevention program among

cancer patients undergoing radiation therapy. University of California- Integrating Quality and Education 2014

A.Chen, of 37

45. Tait L, Wright R, Dyer B, Sittig M, Vaughan AT, Chen AM. Quantitation of serum HPV DNA levels in patients with p16-positive oropharyngeal cancer undergoing dose de-escalated chemoradiotherapy and correlation with PET/CT: Preliminary findings from a prospective trial. ASTRO H&N 2014

46. Chen AM, Wang PC, Daly ME, Cui J, Farwell DG, Purdy JA. Dose-volume analysis of

brachial plexopathy: Results of a prospective screening protocol. ASTRO H&N 2014

47. Moalikyar O, Vaughan AT, Chen AM. HPV expression among salivary gland carcinoma. ASTRO H&N 2014

48. Chen AM, Daley ME, Farwell DG, Luu Q, Donald PJ, Vaughan AV. Function outcomes and quality of life after definitive chemoradiation for human papillomavirus-positive oropharyngeal cancer: implications for dose de-escalation. ASTRO 2013

49. Yu Y, Daly ME, Farwell DG, Fisher J, Luu Q, Donald PJ, Chen AM. T-stage and presence of

level III-IV cervical lymph node metastasis predict for submandibular nodal involvement: implications for submandibular gland-sparing intensity-modulated radiotherapy (IMRT). ASTRO 2013

50. Hess C, Rash D, Daly ME, Farwell DG, Vaughan AV, Chen AM. Competing causes of death

and medical co-morbidities and its impact on radiotherapy compliance among patients with HPV-positive and HPV-negative oropharyngeal cancer. ASTRO 2013

51. Rash D, Daly ME, Farwell DG, Fisher J, Donald PJ, Vaughan AV, Chen AM. Comparison of

clinical outcomes among patients treated by primary surgery versus chemoradiation for locally advanced, HPV-negative squamous cell carcinoma of the oropharynx. ASTRO 2013

52. Daly ME, Chen AM. Does early post-treatment surveillance affect subsequent management

following SBRT for early-stage non-small cell lung cancer? ASTRO 2013

53. Rwigema JC, Chen AM, Wang PC, Lee JM, Garon E, Lee P. Incidental mediastinal dose does not explain low mediastinal node recurrence rates in patients with early-stage NSCLC treated with stereotactic body radiotherapy. ASTRO 2013

54. Chen AM, Daly ME, Farwell DG, Shin C. Electrodiagnostic abnormalities related to brachial

plexus injuries after radiation therapy for head and neck cancer. RSNA 2012

55. Yi SK, Bommer W, Beckett LA, Purdy JA, Chen AM. Prospective evaluation of echocardiographic findings after stereotactic body radiotherapy for lung cancer. ASTRO 2012

56. Li BQ, Brown M, Chen M, Chen AM. Concurrent chemoradiotherapy improves survival

compared to radiation therapy alone for Asian Americans living in California. ASTRO 2012

A.Chen, of 37

57. Yu Y, Cho A, Batth S, Daly ME, Vazquez EG, Farwell DG, Luu Q, Donald PJ, Chen AM. Association between number of positive lymph nodes and outcome among patients treated by surgery and postoperative radiation therapy for head and neck cancer. ASTRO 2012

58. Batth S, Daly ME, Perks J, Stern R, Purdy JA, Chen AM. Differences in clinical outcome

among patients treated using intensity-modulated radiotherapy with and without image-guidance for head and neck cancer. ASTRO 2012

59. Daly ME, Perks J, Chen AM. Survey of practice patterns for the use of stereotactic body

radiotherapy (SBRT) for early-stage lung cancer. ASTRO 2012

60. Hou WH, Daly ME, Lee NY, Farwell DG, Luu Q, Chen AM. Racial disparities in the use of voice-preservation for locally advanced laryngeal cancer. ARS 2012

61. Hauck CR, Daly ME, Farwell DG, Donald PJ, Luu Q, Chen AM. Laryngo-esophageal dysfunction after chemoradiation for larynx cancer. ARS 2012

62. Chen AM, Daly ME, Stern R, Mathai M, Purdy JA. Variability in dose prescriptions for patients undergoing intensity-modulated radiotherapy for head and neck cancer. ARS 2012

63. Chen AM, Li J, Beckett L, Zhara T, Michaud AL, Farwell DG, Luu Q, Purdy JA, Vaughan A. Differential response rates in vivo to irradiation among patients with human papillomavirus (HPV) positive and negative oropharyngeal cancer. ASTRO 2011

64. Hess C, Chen AM. Survey of currently used quality of life indices for patients undergoing

head and neck radiation therapy. ASTRO 2011 65. Yu Y, Purdy JA, Cui J, Michaud A, Chen AM. Dosimetric implications of marginal misses

from less-than-daily IGRT in the setting of head and neck cancer. ASTRO 2011 66. Rowe K, Mathai M, Cui J, Purdy JA, Chen AM. Determination of gonadal dose for patients

undergoing prophylactic radiation for heterotopic bone ossification. ASTRO 2011 67. Khodayari B, Wooten O, Stanic S, Mathai M, Purdy JA, Chen AM. Evaluation of

hippocampal dose among patients receiving intensity-modulated radiotherapy for nasopharyngeal carcinoma. ASTRO 2011

68. Wong J, Huddleston A, Mathai M, Purdy JA, Chen AM. Extended neck, whole-field

intensity-modulated radiotherapy significantly increases dose to brachial plexus compared to split-field technique. ASTRO 2011

69. Yoshida E, Luu Q, Farwell DG, Donald P, Boggan J, Chen AM. Patterns of failure after initial

treatment for neuroendocrine tumors of the sinonasal region. ASTRO 2011 70. Chapman T, Farwell DG, Luu Q, Gillis T, Chen AM. Incidence of osteoradionecrosis after

intensity-modulated radiotherapy for head and neck cancer. ASTRO 2011

A.Chen, of 37

71. Batth S, Mathai M, Farwell D, Daly M, Purdy JA, Chen AM. Evaluation of dose to segements of the brachial plexus among patients treated with IMRT. ASTRO 2011

72. Perks J, Stanic S, Mathai M, Harse R, Siefkin A, Valicenti R, Purdy JA, Chen AM. Failure

mode and effects analysis for delivery of lung stereotactic body radiotherapy. ASTRO 2011

73. Chen AM, Vazquez E, Courquin J, Donald PJ, Farwell DG. Implementation of a tobacco cessation screening clinic among long-term survivors of head and neck cancer. University of California- Integrating quality with education conference 2011

74. Chen AM, Lau DH, Mathai M, Farwell DG, Luu Q, Donald PJ, Purdy JA. Prospective

clinical-dosimetric evaluation of normal tissue tolerance of the brachial plexus among patients treated by intensity-modulated radiotherapy for head and neck cancer. ASTRO 2010

75. Yu Y, Michaud AL, Sreeraman R, Liu T, Purdy JA, Chen AM. Potential utility of image-

guidance to reduce PTV margins for patients treated by IMRT for head and neck cancer: Evaluation of temporal-based protocols. ASTRO 2010

76. Turnbull HE, Mathai M, Lau D, Farwell DG, Luu Q, Purdy JA, Chen AM. Prospective Study

to determine ideal dose constraints for the oral cavity in patients undergoing intensity-modulated radiotherapy for head and neck cancer. ASTRO 2010

77. Li BQ, Turnbull H, Brown M, Yang R, Qi L, Nori D, Chen AM, The California Cancer

Registry Report on the impact of histology and chemoradiation on survival in nasopharyngeal cancer among Asian subgroups. ASTRO 2010

78. Yi S, Perks J, Houston R, Stern R, Purdy JA, Chen AM. Changes in position and volume of

lung cancer target volumes during stereotactic body radiotherapy (SBRT): Is image guidance necessary? ASTRO 2010

79. Lau VH, Leonard S, Goodrich D, Lau DH, Stuart K, Luu Q, Farwell D, Purdy JA, Chen AM.

Voice quality after organ-preservation therapy for laryngeal cancer. ASTRO 2010 80. Chen AM, Hall WH, Li BQ, Guiou M, Wright C, Mathai M, Dublin A, Purdy JA. Intensity-

modulated radiotherapy increases dose to the brachial plexus compared to conventional radiotherapy for head and neck cancer. RTOG 2010

81. Chen AM, Hall WH, Mathai M, Guiou M, Purdy JA. Brachial plexopathy after head and neck

cancer. ASTRO 2009 82. Doshi S, Sreeraman R, Cui J, Mathai M, Yang CC, Purdy JA, Chen AM. Evaluation of dose to

the lacrimal gland among patients treated for head and neck cancer. ASTRO 2009 83. Michaud AL, Yang CC, Liu T, Cui J, Purdy JA, Chen AM. Image guidance is most critical in

the first two weeks for patients treated by radiation therapy for head and neck cancer. ASTRO 2009

A.Chen, of 37

84. Klein EA, Stanic S, Cui J, Mathai M, Do LV, Purdy JA, Chen AM. Dosimetric analysis of the

brachial plexus among patients treated by post-mastectomy radiation therapy for breast cancer. ASTRO 2009

85. Turnbull H, Harse R, Purdy JA, Chen AM. Inter-observer variability in patient positioning

using image guided radiotherapy for head and neck cancer patients undergoing treatment with Tomotherapy. ASTRO 2009

86. Cui J, Li BQ, Purdy JA, Chen AM. Daily MVCT to evaluate the true delivered dose to the

spinal cord, mandible and parotid glands during the head-and-neck cancer radiotherapy. ASTRO 2009

87. Young J, Mathai M, Farwell DG, Luu Q, Purdy JA, Chen AM. Initial clinical experience with

daily image-guide radiotherapy (IGRT) and 3mm planning target volume (PTV) margins in the definitive management of head and neck cancer with IMRT. ASTRO 2009

88. Lam K, Martinez SL, Chen SL, Jung E, Do LV, Chen AM. Racial disparities in the use of

post-mastectomy radiation therapy for women with high-risk breast cancer. ASTRO 2009 89. Marsano J, Won S, Li BQ, Sreeraman R, Michaud AL, Perks J, Purdy JA, Chen AM. Is daily

image-guided radiotherapy (IGRT) really necessary in the treatment of head and neck cancer with intensity-modulated radiotherapy (IMRT)? ASTRO 2009

90. Chen LM, Farwell DG, Luu Q, Chen AM. Postoperative radiation therapy for head and neck

cancer in the setting of orocutaneous fistula. ASTRO 2009 91. Sreeraman R, Doshi S, Cui J, Mathai M, Yang CC, Purdy JA, Chen AM. Clinical-dosimetric

analysis of lacrimal gland dysfunction among patients treated by intensity-modulated radiotherapy for sinonasal tumors. ASTRO 2009

92. Won S, Marsano J, Michaud AL, Sreeraman R, Yang CC, Liu T, Purdy JA, Chen AM. Long-

term single institutional experience with the use of daily image-guided radiotherapy (IGRT) for the treatment of head and neck cancer. ASTRO 2009

93. Stanic S, Mathai M, Do LV, Purdy JA, Chen AM. Addition of a third field significantly

increases dose to the brachial plexus for patients undergoing tangential whole-breast radiotherapy after lumpectomy. ASTRO 2009

94. Yi SK, Hall WH, Mathai M, Dublin AB, Gupta V, Purdy JA, Chen AM. Validating the

RTOG-endorsed brachial plexus contouring atlas. ASTRO 2009 95. Lau VH, Farwell DG, Luu Q, Donald P, Sreeraman R, Purdy JA, Chen AM. Primary radiation

therapy for carcinomas of the paranasal sinus and nasal cavity using IMRT. ASTRO 2009

A.Chen, of 37

96. Jung E, Martinez SR, Chen SL, Do LV, Chen AM. Racial disparities in the use of radiation therapy for women with early-stage breast cancer after lumpectomy. ASTRO 2009

97. Li BQ, Gandour-Edwards R, Bobinski M, Farwell DG, Chen AM. Overstaging of cartilage invasion by multidetector CT scan for laryngeal cancer and its potential effect on the use of organ preservation with chemoradiation. ASTRO 2009

98. Yang CC, Liu T, Mathai M, Purdy JA, Chen AM. IMRT for cancers of the paranasal sinuses and nasal Cavity: A planning study. ASTRO 2009

99. Chen AM, Perks J, Jennelle R, Sreeraman, Michaud AL, Li BQ, Vijayakumar S, Purdy JA.

Comparison of daily versus less-than-daily image-guided radiotherapy protocols in the treatment of head and neck cancer. ASTRO 2008

100. Jennelle RH, Sreeraman R, Michaud A, Yang CC, Purdy JA, Chen AM. Impact of body

mass index on patient alignment and setup variations as determined using daily cone-beam computed tomography for head and neck cancer. ASTRO 2008

101. Li BQ, Li D, Lau DH, Farwell DG, Luu Q, Rocke DM, Newman K, Courquin J, Purdy JA,

Chen AM. Clinical-dosimetric measures of dysphagia including gastrostomy-tube dependence among head and neck cancer patients treated definitively by intensity-modulated radiotherapy with concurrent chemotherapy. ASTRO 2008

102. Sreeraman R, Jennelle R, Yang CC, Purdy JA, Vijayakumar S, Chen AM. Significance of

unplanned treatment interruptions on local-regional control among patients treated by radiation therapy for head and neck cancer. ASTRO 2008

103. Chen LM, Vaughan A, Farwell DG, Luu Q, Purdy JA, Vijayakumar S, Chen AM. Head

and neck cancer among lifelong never-smokers and ever-smokers: Matched-paired analysis of outcomes after radiation therapy. ASTRO 2008

104. Gupta V, Yang CC, Liu T, Purdy JA, Chen AM. Analysis of the dose delivered to the

pituitary gland for patients undergoing intensity-modulated radiotherapy for nasopharynx and paranasal sinus cancer. ASTRO 2008

105. Hall WH, Mathai M, Guiou M, Wright C, Purdy JA, Chen AM. Comparison of brachial

plexus dose using conventional 3-field versus IMRT planning for head and neck cancer. ASTRO 2008

106. Cheng S, Yang CC, Liu T, Jennelle R, Purdy JA, Chen AM. Daily kilovoltage CT imaging

in the head and neck documents significant volume change and positional shifts during postoperative IMRT. ASTRO 2008

107. Perks J, Chen AM, Jennelle R, Franklin S, Liu T, Palo BM, Purdy JA. Vector analysis of

patient setup with image guided radiotherapy via cone beam CT. ASTRO 2008

A.Chen, of 37

108. Chen AM, Yang CC, Narayan S, Farwell DG, Purdy JA, Vijayakumar S. Patterns of failure according to irradiation technique for patients treated postoperatively for head and neck cancer: Does IMRT increase the incidence of marginal misses? ASTRO 2008

109. Guiou M, Narayan S, Vijayakumar S, Chen AM, Radiation therapy for head and neck

cancer in the setting of human immunodeficiency virus. ASTRO 2008 110. Li BQ, Jennelle R, Yang CC, Vijayakumar S, Chen AM. Clinical-dosimetric analysis of

objective and subjective measures of dysphagia in head and neck cancer patients treated with radiation therapy. ASTRO 2007

111. Kim J, Farwell DG, Vijayakumar S, Purdy JA, Chen AM. Incidence of second malignancy

after definitive treatment for head and neck cancer: analysis of the Surveillance, Epidemiology, and End Results program database. ASTRO 2007

112. Hall WH, Guiou M, Lee NY, Dublin A, Vijayakumar V, Purdy JA, Chen AM.

Development and validation of a standardized method for contouring the brachial plexus: Preliminary dosimetric analysis among patients treated with IMRT for head and neck cancer. ASTRO 2007

113. Yang CC, Liu T, Mathai, Purdy JA, Chen AM. Utility of tomotherapy for nasopharyngeal

cancer. ASTRO 2007 114. Chen AM, Lee NY, Eisele DW. Second malignancies after salivary gland cancer: A

population-based analysis. ASTRO 2007

115. Chen AM, Gottschalk T, Jahan D, Krieg R. Outcome of patients treated with definitive versus palliative radiation therapy for locally advanced non-small cell lung cancer after poor radiographic response to induction chemotherapy. ASTRO 2005

curriculum vitae · curriculum vitae . allen m. chen, m.d. department of radiation oncology ....

Documents